J05AJ Integrase Inhibitors, antiinfectives for systematic use
ATC group of level 4 – chemical subgroup · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 15 medicines in this group and its subgroups.
- 13 prescription only (POM)
- 2 no longer supplied or not available
Place in the ATC classification
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
-
J05AJ Integrase Inhibitors, antiinfectives for systematic use 15 medicines
- J05AJ01 raltegravir 7 medicines
- J05AJ03 dolutegravir 4 medicines
- J05AJ04 cabotegravir 4 medicines
-
J05AJ Integrase Inhibitors, antiinfectives for systematic use 15 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
1 more subgroup has no medicine with a leaflet on this site.
Active substances in the group
- Cabotegravir 4 medicines
- Dolutegravir 4 medicines
- Raltegravir 7 medicines
Medicines in the group and its subgroups
| Medicine | Legal category |
|---|---|
| Apretude 600 mg prolonged-release suspension for injection SPC (J05AJ04 cabotegravir) | Prescription only (POM) |
| Dolutegravir (Tivicay) dispersible tablets 5 mg SPC (J05AJ03 dolutegravir) | Prescription only (POM) |
| Dolutegravir (Tivicay) film-coated tablets 10 mg SPC no longer supplied (J05AJ03 dolutegravir) | – |
| Dolutegravir (Tivicay) film-coated tablets 25 mg SPC no longer supplied (J05AJ03 dolutegravir) | – |
| Dolutegravir (Tivicay) film-coated tablets 50 mg SPC (J05AJ03 dolutegravir) | Prescription only (POM) |
| Isentress 100 mg chewable tablets SPC (J05AJ01 raltegravir) | Prescription only (POM) |
| Isentress 100 mg granules for oral solution SPC (J05AJ01 raltegravir) | Prescription only (POM) |
| Isentress 25 mg chewable tablets SPC (J05AJ01 raltegravir) | Prescription only (POM) |
| Isentress 400 mg film-coated tablets SPC (J05AJ01 raltegravir) | Prescription only (POM) |
| Isentress 600 mg film-coated tablets SPC (J05AJ01 raltegravir) | Prescription only (POM) |
| Raltegravir 400 mg film-coated tablets SPC (J05AJ01 raltegravir) | Prescription only (POM) |
| Raltegravir 600 mg film-coated tablets SPC (J05AJ01 raltegravir) | Prescription only (POM) |
| Vocabria 30 mg film-coated tablets SPC (J05AJ04 cabotegravir) | Prescription only (POM) |
| Vocabria 400 mg prolonged-release suspension for injection SPC (J05AJ04 cabotegravir) | Prescription only (POM) |
| Vocabria 600 mg prolonged-release suspension for injection SPC (J05AJ04 cabotegravir) | Prescription only (POM) |
Other groups of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 40 medicines
- J05AD Phosphonic acid derivatives, direct acting antivirals 2 medicines
- J05AE Protease inhibitors, direct acting antivirals 75 medicines
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05AG Non-nucleoside reverse transcriptase inhibitors 32 medicines
- J05AH Neuraminidase inhibitors, direct acting antivirals 14 medicines
- J05AP Antivirals for treatment of HCV infections 25 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05AX Other antivirals 27 medicines
Other names of the ATC group
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AJ
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.